First Tracks Biotherapeutics, Inc.
NASDAQFirst Tracks Biotherapeutics enters the second week of July with an interesting split: the Street is firmly in the bull camp, yet the stock has given back ground after a strong month, and institutional ownership tells a complicated story of a major holder who already cashed out. The Street's positioning on TRAX is broadly constructive, but the analyst picture is fresher than most…
Snapshot as of 9 Aug 2026
First Tracks Biotherapeutics enters the second week of July with an interesting split: the Street is firmly in the bull camp, yet the stock has given back ground after a strong month, and institutional ownership tells…
First Tracks Biotherapeutics enters the week of May 11 with a stark contradiction at its centre: six Wall Street firms initiated coverage in the past month with unanimous bullish ratings, yet the stock has shed 31%…
TRAX — First Tracks Biotherapeutics — enters the weekend carrying two stories in direct tension: one of the more aggressive analyst coverage launches seen for a small-cap biotech, and a Friday-evening resale prospectus…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TRAX — free to start on ORTEX.
Sign up for free →Open TRAX on ORTEX